The Flow Cytometry Core (FCC), in existence since 1982, is a state-of-the-art shared resource that provides Cancer Center investigators access to high quality, cost effective flow cytometry services and technology. The facility occupies approximately 1850 sq. ft. within the Cancer Center wing in Jordan Hall. By providing a variety of instrumentation and the scientific expertise necessary to effectively use these technologies, the facility serves to enhance the scope and quality of cancer research performed at the University. The FCC incorporates a variety of technologies into its services based on the needs of the Cancer Center investigators. The instrumentation available is compatible wide array of flow cytometric applications such as subpopulation identification/quantification, molecular detection, measurement of DNA and RNA content, apoptosis, transcriptional activity, cell viability, membrane potential, cell sorting, and bead based immunoassays. The FCC provides cell sorting in enclosed Biosafety Cabinets to allow for the safe sorting of primary human samples, as well as retro/lentivirally transfected cells. The sorters are capable of up to 17 parameters, with six- way, single cell and index sorting capabilities for downstream single cell genomics assays. The recent addition of the CyTOF2 mass cytometer, through joint funding from the President's office and several departments/centers, allows major advancements in the evaluation of highly dimensional biological systems to unravel the complexity of cancers and their associated immune responses. The imaging flow cytometry services provide additional capabilities for evaluating a variety of measurements at the single cell level, with high throughput and statistical robustness. Direct collaborations with Cancer Center investigators have produced novel methods and approaches for studying cancer that have been published. The services and expertise offered by the FCC play a key role in the study of many types of cancer, as well as the immune responses to cancers. The FCC staff is highly qualified with many years of experience and are all certified by the International Cytometry Certification Exam (ICCE). In addition to providing training on the instrumentation, FCC staff provide consultation in experimental design, sample preparation and data analysis. The facility has recently added a bio-analysis specialist to assist Cancer Center investigators with unraveling the complexity of the data generated in the core. Specialized training classes are offered for those researchers who wish to better understand the principles and techniques employed in this technology and prefer to directly acquire and/or analyze their own samples. Researchers have the option, once trained, of performing their own analysis or they can choose to utilize the expertise of the FCC's staff to run their samples for them.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA044579-29
Application #
9854915
Study Section
Subcommittee H - Clinical Groups (NCI)
Project Start
Project End
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
29
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Banizs, Anna B; Huang, Tao; Nakamoto, Robert K et al. (2018) Endocytosis Pathways of Endothelial Cell Derived Exosomes. Mol Pharm :
Jia, Deshui; Augert, Arnaud; Kim, Dong-Wook et al. (2018) Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer Discov 8:1422-1437
Manukyan, Arkadi; Kowalczyk, Izabela; Melhuish, Tiffany A et al. (2018) Analysis of transcriptional activity by the Myt1 and Myt1l transcription factors. J Cell Biochem 119:4644-4655
Engelhard, Victor H; Rodriguez, Anthony B; Mauldin, Ileana S et al. (2018) Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity. J Immunol 200:432-442
Martins, André L; Walavalkar, Ninad M; Anderson, Warren D et al. (2018) Universal correction of enzymatic sequence bias reveals molecular signatures of protein/DNA interactions. Nucleic Acids Res 46:e9
Michaels, Alex D; Newhook, Timothy E; Adair, Sara J et al. (2018) CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer. Clin Cancer Res 24:1415-1425
Shi, Lei; Li, Kang; Guo, Yizhan et al. (2018) Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer. Proc Natl Acad Sci U S A 115:11808-11813
Yang, Jun; LeBlanc, Francis R; Dighe, Shubha A et al. (2018) TRAIL mediates and sustains constitutive NF-?B activation in LGL leukemia. Blood 131:2803-2815
Kulling, Paige M; Olson, Kristine C; Hamele, Cait E et al. (2018) Dysregulation of the IFN-?-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia. PLoS One 13:e0193429
Grant, Margaret J; Loftus, Matthew S; Stoja, Aiola P et al. (2018) Superresolution microscopy reveals structural mechanisms driving the nanoarchitecture of a viral chromatin tether. Proc Natl Acad Sci U S A 115:4992-4997

Showing the most recent 10 out of 539 publications